Triap1 upregulation promotes escape from mitotic-slippage-induced G1 arrest
Mattia Pavani,
Elena Chiroli,
Camilla Cancrini,
Fridolin Gross,
Paolo Bonaiuti,
Stefano Villa,
Fabio Giavazzi,
Vittoria Matafora,
Angela Bachi,
Luca L. Fava,
Tiziana Lischetti,
Andrea Ciliberto
Affiliations
Mattia Pavani
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy; Corresponding author
Elena Chiroli
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy
Camilla Cancrini
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy
Fridolin Gross
ImmunoConcEpT, CNRS UMR5164, Université de Bordeaux, 33076 Bordeaux, France
Paolo Bonaiuti
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy
Stefano Villa
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Universitá degli Studi di Milano, 20090 Segrate, Italy
Fabio Giavazzi
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Universitá degli Studi di Milano, 20090 Segrate, Italy
Vittoria Matafora
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy
Angela Bachi
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy
Luca L. Fava
Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology – CIBIO, University of Trento, Trento, Italy
Tiziana Lischetti
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy; Corresponding author
Andrea Ciliberto
IFOM ETS – The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy; Pázmány Péter Catholic University, Faculty of Information Technology and Bionics, 1083 Budapest, Hungary; Corresponding author
Summary: Drugs targeting microtubules rely on the mitotic checkpoint to arrest cell proliferation. The prolonged mitotic arrest induced by such drugs is followed by a G1 arrest. Here, we follow for several weeks the fate of G1-arrested human cells after treatment with nocodazole. We find that a small fraction of cells escapes from the arrest and resumes proliferation. These escaping cells experience reduced DNA damage and p21 activation. Cells surviving treatment are enriched for anti-apoptotic proteins, including Triap1. Increasing Triap1 levels allows cells to survive the first treatment with reduced DNA damage and lower levels of p21; accordingly, decreasing Triap1 re-sensitizes cells to nocodazole. We show that Triap1 upregulation leads to the retention of cytochrome c in the mitochondria, opposing the partial activation of caspases caused by nocodazole. In summary, our results point to a potential role of Triap1 upregulation in the emergence of resistance to drugs that induce prolonged mitotic arrest.